Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

Rights & Permissions Free Resources PDF FORMAT Display this book on your site! Related Titles Assessment of Future Scientific Needs for Live Variola Virus Live Variola Virus:Considerations for Continuing Research Other Related Titles (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors (1996) National Academy of Sciences (NAS) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Contents." (NAS Colloquium) Genetic Engineering of Viruses and Viral Vectors. Washington, DC: The National Academies Press, 1996. Please select a format: Page I   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Table of Contents Papers from a National Academy of Sciences Colloquium: Genetic Engineering of Viruses and Viral Vectors     Genetic engineering of viruses and of virus vectors: A preface Peter Palese and Bernard Roizman   11287     Site-specific integration by adeno-associated virus R.Michael Linden, Peter Ward, Catherine Giraud, Ernest Winocour, and Kenneth I.Berns   11288–11294     Oncogenic potential of the adenovirus E4orf6 protein Mary Moore, Nobuo Horikoshi, and Thomas Shenk   11295–11301     Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma Manuel Caruso, Khiem Pham-Nguyen, Yok-Lam Kwong, Bisong Xu, Ken-Ichiro Kosai, Milton Finegold, Savio L.C.Woo, and Shu-Hsia Chen   11302–11306     The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors Bernard Roizman   11307–11312     The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors Samita S.Andreansky, Bin He, G.Yancey Gillespie, Liliana Soroceanu, James Markert, Joany Chou, Bernard Roizman, and Richard J.Whitley   11313–11318     Replication-defective herpes simplex virus vectors for gene transfer in vivo Peggy Marconi, David Krisky, Thomas Oligino, Pietro L.Poliani, Ramesh Ramakrishnan, William F.Goins, David J.Fink, and Joseph C.Glorioso   11319–11320     A deletion mutant in the human cytomegalovirus gene encoding IE1491aa is replication defective due to a failure in autoregulation Edward S.Mocarski, George W.Kemble, John M. Lyle, and Richard F.Greaves   11321–11326     Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains Thomas R.Jones, Emmanuel J.H.J.Wiertz, Lei Sun, Kenneth N.Fish, Jay A.Nelson, and Hidde L.Ploegh   11327–11333     Epstein-Barr virus vectors for gene delivery to B lymphocytes Erle S.Robertson, Tadamasa Ooka, and Elliott D.Kieff   11334–11340     Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Bernard Moss   11341–11348     Applications of pox virus vectors to vaccination: An update Enzo Paoletti   11349–11353 Page I Contents (R1-R2) Genetic engineering of viruses and of virus vectors: A preface (11287-11287) Site-specific integration by adeno-associated virus (11288-11294) Oncogenic potential of the adenovirus E4orf6 protein (11295-11301) Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma (11302-11306) The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors (11307-11312) The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors (11313-11318) Replication-defective herpes simplex virus vectors for gene transfer in vivo (11319-11320) A deletion mutant in the human cytomegalovirus gene encoding IEl 49laa is replication defective due to a failure in autoregulation (11321-11326) Human cytomegalovirus U53 impairs transport and maturation of major histocompatibility complex class I heavy chains (11327-11333) Epstein-Barr virus vectors for gene delivery to B lymphocytes (11334-11340) Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety (11341-11348) Applications of pox virus vectors to vaccination: An update (11349-11353) Negative-strand RNA viruses: Genetic engineering and applications (11354-11358) Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles (11359-11365) Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein (11366-11370) Alphavirus-based expression vectors: Strategies and applications (11371-11377) Early events in poliovirus infection: Virus-receptor interactions (11378-11381) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector (11382-11388) Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses (11389-11394) Development of HIV vectors for anti-HIV gene therapy (11395-11399) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes (11400-11406) Cell-surface receptors for retroviruses and implications for gene transfer (11407-11413) Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease (11414-11420) Fusigenic viral liposome for gene therapy in cardiovascular diseases (11421-11425)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page R1
Proceedings of the National Academy of Sciences of the United States of America PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA Table of Contents Papers from a National Academy of Sciences Colloquium: Genetic Engineering of Viruses and Viral Vectors     Genetic engineering of viruses and of virus vectors: A preface Peter Palese and Bernard Roizman   11287     Site-specific integration by adeno-associated virus R.Michael Linden, Peter Ward, Catherine Giraud, Ernest Winocour, and Kenneth I.Berns   11288–11294     Oncogenic potential of the adenovirus E4orf6 protein Mary Moore, Nobuo Horikoshi, and Thomas Shenk   11295–11301     Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma Manuel Caruso, Khiem Pham-Nguyen, Yok-Lam Kwong, Bisong Xu, Ken-Ichiro Kosai, Milton Finegold, Savio L.C.Woo, and Shu-Hsia Chen   11302–11306     The function of herpes simplex virus genes: A primer for genetic engineering of novel vectors Bernard Roizman   11307–11312     The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors Samita S.Andreansky, Bin He, G.Yancey Gillespie, Liliana Soroceanu, James Markert, Joany Chou, Bernard Roizman, and Richard J.Whitley   11313–11318     Replication-defective herpes simplex virus vectors for gene transfer in vivo Peggy Marconi, David Krisky, Thomas Oligino, Pietro L.Poliani, Ramesh Ramakrishnan, William F.Goins, David J.Fink, and Joseph C.Glorioso   11319–11320     A deletion mutant in the human cytomegalovirus gene encoding IE1491aa is replication defective due to a failure in autoregulation Edward S.Mocarski, George W.Kemble, John M. Lyle, and Richard F.Greaves   11321–11326     Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains Thomas R.Jones, Emmanuel J.H.J.Wiertz, Lei Sun, Kenneth N.Fish, Jay A.Nelson, and Hidde L.Ploegh   11327–11333     Epstein-Barr virus vectors for gene delivery to B lymphocytes Erle S.Robertson, Tadamasa Ooka, and Elliott D.Kieff   11334–11340     Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Bernard Moss   11341–11348     Applications of pox virus vectors to vaccination: An update Enzo Paoletti   11349–11353

OCR for page R2
Proceedings of the National Academy of Sciences of the United States of America     Negative-strand RNA viruses: Genetic engineering and applications Peter Palese, Hongyong Zheng, Othmar G. Engelhardt, Stephan Pleschka, and Adolfo García-Sastre   11354–11358     Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles Matthias J.Schnell, Linda Buonocore, Evelyne Kretzschmar, Erik Johnson, and John K.Rose   11359–11365     Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein Teshome Mebatsion and Karl-Klaus Conzelmann   11366–11370     Alphavirus-based expression vectors: Strategies and applications Ilya Frolov, Thomas A.Hoffman, Béla M.Prágai, Sergey A.Dryga, Henry V.Huang, Sondra Schlesinger, and Charles M.Rice   11371–11377     Early events in poliovirus infection: Virus-receptor interactions Vincent R.Racaniello   11378–11381     Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector Luigi Naldini, Ulrike Blömer, Fred H.Gage, Didier Trono, and Inder M.Verma   11382–11388     Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses S.Monroe Duboise, Jie Guo, Ronald C.Desrosiers, and Jae U.Jung   11389–11394     Development of HIV vectors for anti-HIV gene therapy Eric Poeschla, Pierre Corbeau, and Flossie Wong-Staal   11395–11399     A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes Daniel S.Ory, Beverly A.Neugeboren, and Richard C.Mulligan   11400–11406     Cell-surface receptors for retroviruses and implications for gene transfer A.Dusty Miller   11407–11413     Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease William L.McClements, Marcy E.Armstrong, Robert D.Keys, and Margaret A.Liu   11414–11420     Fusigenic viral liposome for gene therapy in cardiovascular diseases Victor J.Dzau, Michael J.Mann, Ryuichi Morishita, and Yasufumi Kaneda   11421–11425